Similarly, Jang et al. showed that in breast cancer, 15-d-PGJ-2 decreased the invasive capacity of breast cancer cells (MCF-7) by regulating MMP-9 expression, which was inhibited by NF-κB/AP-1 activation. Here, MMP9 is linked to breast carcinoma.